IAN-15B

• Description :

  IAN-15B has high selectivity and potent ST6GAL1 inhibitors (IC50 = 3.3 μM) . IAN-15B has significant anti migratory and anti angiogenic effects. IAN-15B can be used in the research of cancer such as breast cancer[1].

• UNSPSC :

  12352005

• Target :

  Sialyltransferase

• Related Pathways :

  Metabolic Enzyme/Protease

• Field of Research :

  Cancer

• Smiles :

  [H][C@]12CC[C@@]3([C@H](CC[C@]3([C@@]1(CC[C@@]4(C[C@@H](CC[C@]24C)O)[H])[H])[H])[C@@H](CCC(N[C@@H](C(O)=O)CC(C5=CNC6=C5C=C(C=C6)N=[N+]=[N-])C7=CNC8=C7C=C(C=C8)N=[N+]=[N-])=O)C)C

• Molecular Formula :

  C44H55N9O4

• Molecular Weight :

  773.97

• References & Citations :

  [1]Concio CAP, et al. Novel lithocholic acid-diindolylmethane hybrids as potent sialyltransferase inhibitors targeting triple-negative breast cancer: a molecular hybridization approach. RSC Med Chem. 2025 Aug 28;16 (10) :5070-5083.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported